The antidepressant-like effect of galanin in the dorsal raphe nucleus of rats involves GAL2 receptors. 2018

Mayara Machado de Souza, and Gabriela Pandini Silote, and Leticia Santos Herbst, and Vinicius Rafael Funck, and Samia Regiane Lourenço Joca, and Vanessa Beijamini
Department of Pharmaceutical Sciences, Health Science Centre, Federal University of Espirito Santo, Vitoria, ES, 29043-900, Brazil.

Galanin is a neuropeptide distributed in human and rat brain regions that are involved with emotional regulation, such as the dorsal raphe nucleus (DRN). Galanin effects in the DRN are mediated by GAL1 and GAL2 receptors. Intracerebral infusion of a GAL2 (AR-M1896) or a GAL1 (M617) agonist induced either antidepressant or depressive-like effect, respectively, in rats exposed to the forced swimming test (FST). However, it is not clear if GAL1 and/or GAL2 receptors present in the DRN would be involved in such effects. Therefore, we investigated the effects induced by intra-DRN infusion of galanin (0.3 nmol), AR-M1896 (1 nmol, GAL2 agonist), or M617 (GAL1 agonist) in rats exposed to the FST. Galanin and AR-M1896 intra-DRN administration induced antidepressant-like effect in the FST. However, M617 did not induce any change in the FST. Neither M617 nor AR-M1896 changed the locomotor activity of rats in the open field test. Intra-DRN pre-treatment with M871 (1 nmol), a selective GAL2 antagonist, counteracted the antidepressant-like effect induced by galanin. These results suggest that galanin signaling through GAL2 receptors in the DRN produces triggers antidepressant-like effect.

UI MeSH Term Description Entries
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D008297 Male Males
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011498 Protein Precursors Precursors, Protein
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D013550 Swimming An activity in which the body is propelled through water by specific movement of the arms and/or the legs. Swimming as propulsion through water by the movement of limbs, tail, or fins of animals is often studied as a form of PHYSICAL EXERTION or endurance.
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Mayara Machado de Souza, and Gabriela Pandini Silote, and Leticia Santos Herbst, and Vinicius Rafael Funck, and Samia Regiane Lourenço Joca, and Vanessa Beijamini
January 2005, Proceedings of the National Academy of Sciences of the United States of America,
Mayara Machado de Souza, and Gabriela Pandini Silote, and Leticia Santos Herbst, and Vinicius Rafael Funck, and Samia Regiane Lourenço Joca, and Vanessa Beijamini
February 2008, Neurochemical research,
Mayara Machado de Souza, and Gabriela Pandini Silote, and Leticia Santos Herbst, and Vinicius Rafael Funck, and Samia Regiane Lourenço Joca, and Vanessa Beijamini
November 2016, Behavioural brain research,
Mayara Machado de Souza, and Gabriela Pandini Silote, and Leticia Santos Herbst, and Vinicius Rafael Funck, and Samia Regiane Lourenço Joca, and Vanessa Beijamini
August 1997, Hormones and behavior,
Mayara Machado de Souza, and Gabriela Pandini Silote, and Leticia Santos Herbst, and Vinicius Rafael Funck, and Samia Regiane Lourenço Joca, and Vanessa Beijamini
January 2011, Neuropharmacology,
Mayara Machado de Souza, and Gabriela Pandini Silote, and Leticia Santos Herbst, and Vinicius Rafael Funck, and Samia Regiane Lourenço Joca, and Vanessa Beijamini
January 1992, Physiology & behavior,
Mayara Machado de Souza, and Gabriela Pandini Silote, and Leticia Santos Herbst, and Vinicius Rafael Funck, and Samia Regiane Lourenço Joca, and Vanessa Beijamini
December 2013, Peptides,
Mayara Machado de Souza, and Gabriela Pandini Silote, and Leticia Santos Herbst, and Vinicius Rafael Funck, and Samia Regiane Lourenço Joca, and Vanessa Beijamini
August 1997, Endocrine journal,
Mayara Machado de Souza, and Gabriela Pandini Silote, and Leticia Santos Herbst, and Vinicius Rafael Funck, and Samia Regiane Lourenço Joca, and Vanessa Beijamini
September 2008, Neuroscience research,
Mayara Machado de Souza, and Gabriela Pandini Silote, and Leticia Santos Herbst, and Vinicius Rafael Funck, and Samia Regiane Lourenço Joca, and Vanessa Beijamini
May 2018, Brain research,
Copied contents to your clipboard!